23.02.2013 Views

LabAutomation 2006 - SLAS

LabAutomation 2006 - SLAS

LabAutomation 2006 - SLAS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>LabAutomation</strong><strong>2006</strong><br />

10:30 am Wednesday, January 25, <strong>2006</strong> Track 3: High-Throughput Technologies Room: Learning Center<br />

Wyndham Palm Springs Hotel<br />

Zhong Zhong<br />

Co-Author(s)<br />

Cell & Molecular Technologies, Inc.<br />

Natalie Fursov, Cell & Molecular Technologies, Inc.<br />

Phillipsburg, New Jersey<br />

zzhong@cmt-inc.net<br />

Kevin Lee. Sentigen Biosciences<br />

Mark Federici, Roland Tacke, Tom Livelli<br />

Cell & Molecular Technologies, Inc.<br />

Rapid Evaluation of Compounds’ Off-Target Activities Against GPCRs by Tango Assay<br />

System, a Novel Reporter Technology<br />

We have developed a new G-protein coupled receptors (GPCR) profiling panel based on Sentigen Biosciences’ TangoTM Assay System.<br />

Unlike conventional compound selectivity services that utilize biochemical or membrane binding methods, the Tango Assay Profiling system<br />

employs a functional cell-based assay that provides information about efficacy and agonism/antagonism properties. A large cryopreserved<br />

cell bank has been set up in which each cell type expresses one of the 54 selected GPCRs in conjunction with Tango Assay components.<br />

We demonstrated that we can thaw cells from the cell bank to generate custom panels on demand to profile agonism/antagonism<br />

activities of compounds on an array of GPCRs.<br />

Activation of GPCR signaling is in general tightly coupled with subsequent receptor desensitization, a process mediated by the recruitment<br />

of intracellular arrestin proteins to the activated receptor. Tango is a luciferase-based chemiluminescent assay that detects ligand-induced<br />

activation/inactivation of target receptor by quantitatively measuring its interaction with arrestin. The assay design does not depend on<br />

knowledge of the G-protein signaling specificity of the target receptor. In addition, Tango Assay System permits the selective interrogation<br />

of the specific target receptor, and is not affected by signaling mediated by endogenous receptors. The high sensitivity of the assay allows<br />

detection of receptor-ligand interactions without the need of over-expressing target receptor or singaling components. We will present data<br />

to demonstrate that the Tango assays are broadly applicable to all classes of GPCRs. Assays’ homogeneous format and simple workflow<br />

make it ideal for GPCR panel profiling.<br />

10:30 am Monday, January 23, <strong>2006</strong> Track 4: Informatics Room: Madera<br />

Wyndham Palm Springs Hotel<br />

John Davies<br />

Novartis<br />

Cambridge, Massachusetts<br />

john-W.davies@novartis.com<br />

An Holistic Approach to HTS Data Triaging<br />

A number of companies today are trying to offset attrition rates in the drug discovery process by simply widening their pipeline. Companies<br />

are now running more screens with larger collections of compounds than they have ever done before. This is creating a vast amount of<br />

HTS data which often, but not always, feeds into an automated IT analysis platform. At this stage little, if anything, is done to analyze and<br />

triage the entire data set. Even less is done to apply orthogonal data mining methods which can increase SAR knowledge. We will show<br />

a number of different approaches we have employed to analyze large-scale HTS data for the purposes of increasing its intrinsic chemical<br />

and biological information content.<br />

80

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!